Diagnosis and Complication Risk Assessment of Pancreatic Diabetes within Normal Value Ranges of Leuc
- 总结
- This method use rapid or Automatic test device for procalcitonin blood levels.
- 技术优势
- This patent can use for daily complication risk Assessment of all diabetic patients and save lifes, suffering from the diabetic complications at all around the world. it is more important method than Hemoglobin A1c. Because all diabetic complications can monitorizing using one marker (procalcitonin) in 24 hours period. New technology of insulin pump system or traditional diabetes mellitus therapy need this invention for proper diabetic complication (retinopathy, nephropathy,neuropathy) treatment
- 申请号码
- EP20120154587
- 覆盖范围
- EPO designated contracting states
- 商品和服务
- License agreement
- 专利信息
- patent application
- 国家/地区
- 土耳其
欲了解更多信息，请点击 这里
